John McDonough - 01 Jul 2021 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Reporting relationship: Director
Issuer ticker: TTOO
Reported as of: 01 Jul 2021
Net transaction value: -$21,091
SEC form: 4
Accepted by SEC: 02 Jul 2021, 16:00:23 UTC
Prior SEC filing: 29 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ John Sprague, Attorney-in-Fact

Key filing fact

John McDonough filed Form 4 for T2 Biosystems, Inc. (TTOO) on 02 Jul 2021.

Key facts

This page summarizes John McDonough's Form 4 filing for T2 Biosystems, Inc. (TTOO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2021, 16:00.

Change

Previous filing in this sequence was filed on 29 Jun 2021.
Current net transaction value: -$21,091.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TTOO transaction

Common Stock

Sale

Transaction value: $21,091
Shares: -18,182
Change %: -3.4%
Price: $1.16
Shares after: 516,386
Date: 01 Jul 2021
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021, to cover payment of tax liability incident to the vesting of restricted stock units.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.16 to $1.19. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.